What companies are XBI's competitors?

State Street SPDR S&P Biotech ETF (XBI)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does XBI compare to its peers?

The peer comparison table on this page shows State Street SPDR S&P Biotech ETF (XBI) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does XBI operate in?

State Street SPDR S&P Biotech ETF (XBI) operates in the Asset Management industry within the Financial Services sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

XBI

State Street SPDR S&P Biotech ETF

AMEX·Asset Management · Financial Services

$152.23$0.12+0.08%

After hours·$151.99−0.16%

Market cap$7.96B·Market closed·Jul 23 8:00 PM UTC

Frequently Asked Questions About XBI

What companies are XBI's competitors?: State Street SPDR S&P Biotech ETF (XBI)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does XBI compare to its peers?: The peer comparison table on this page shows State Street SPDR S&P Biotech ETF (XBI) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does XBI operate in?: State Street SPDR S&P Biotech ETF (XBI) operates in the Asset Management industry within the Financial Services sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

XBI

State Street SPDR S&P Biotech ETF

AMEX·Asset Management · Financial Services

$152.23$0.12+0.08%

After hours·$151.99−0.16%

Market cap$7.96B·Market closed·Jul 23 8:00 PM UTC

Peers


BBUS	JPMorgan BetaBuilders U.S. Equity ETF	$134.67	$8.6B
IDV	iShares International Select Dividend ETF	$43.47	$8.1B
TCAF	T. Rowe Price Capital Appreciation Equity ETF	$41.20	$7.4B
EWZ	iShares MSCI Brazil ETF	$36.62	$7.3B
FDL	First Trust Morningstar Dividend Leaders Index Fund	$51.03	$7.3B
AIQ	Global X - Artificial Intelligence & Technology ETF	$60.14	$7.0B
VOOV	Vanguard S&P 500 Value ETF	$222.75	$6.7B
BBIN	JPMorgan BetaBuilders International Equity ETF	$78.35	$6.6B
KBWB	Invesco KBW Bank ETF	$97.12	$5.5B
XAR	State Street SPDR S&P Aerospace & Defense ETF	$264.30	$4.5B

Frequently Asked Questions About XBI

What companies are XBI's competitors?: State Street SPDR S&P Biotech ETF (XBI)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does XBI compare to its peers?: The peer comparison table on this page shows State Street SPDR S&P Biotech ETF (XBI) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does XBI operate in?: State Street SPDR S&P Biotech ETF (XBI) operates in the Asset Management industry within the Financial Services sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.